Fukuda Denshi Co., Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2022
December 23, 2021 at 03:30 am EST
Share
Fukuda Denshi Co., Ltd. provided consolidated earnings guidance for the fiscal year ending March 31, 2022. For the year ending March 31, 2022, on consolidated basis, the company expects net sales of JPY 125,000 million, operating profit of JPY 15,000 million and profit attributable to owners of parent of JPY 11,000 million or JPY 727.44 per share.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
FUKUDA DENSHI CO., LTD. 
